Responses
Other content recommended for you
- Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
- A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening—a qualitative analysis
- Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?
- Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
- Primary goals, information-giving and men’s understanding: a qualitative study of Australian and UK doctors’ varied communication about PSA screening
- Prostate cancer screening and the management of clinically localized disease
- Screening for prostate cancer remains controversial
- Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening
- Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
- Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study